CRLBF (Cresco Labs) Cyclically Adjusted Book per Share: $-6.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CRLBF Cresco Labs Inc CRLBF
29 GF Score
Price $0.76
GF Value $0.87
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cresco Labs Cyclically Adjusted Book per Share?

Cresco Labs CRLBF +2.54% 29 Cyclically Adjusted Book per Share is $-6.05 as of Jun. 2026. GuruFocus rates CRLBF with a GF Score™ of 29/100 and a GF Value™ of $0.87 (Modestly Undervalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cresco Labs's adjusted book value per share for the three months ended in Jun. 2026 was $0.963. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $-6.05 for the trailing ten years ended in Jun. 2026.

During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 20.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cresco Labs was 20.20% per year. The lowest was -42.00% per year. And the median was -5.40% per year.

As of today (2026-09-04), Cresco Labs's current stock price is $0.76. Cresco Labs's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $-6.05. Cresco Labs's Cyclically Adjusted PB Ratio of today is .


Cresco Labs  (OTCPK:CRLBF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cresco Labs Cyclically Adjusted Book per Share Related Terms


Cresco Labs Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Cyclically Adjusted Book per Share Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.25 -15.13 -13.63 -10.02 -7.76

Cresco Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.16 -8.40 -7.76 -6.82 -6.05

CRLBF vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Cyclically Adjusted PB Ratio falls into.


CRLBF
29GF Score
Cresco Labs Inc CRLBF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cresco Labs's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.963/333.9520*333.9520
=0.963

Current CPI (Jun. 2026) = 333.9520.

Cresco Labs Quarterly Data

Book Value per Share CPI Adj_Book
201607 -24.257 240.628 -33.665
201610 -23.829 241.729 -32.920
201701 -26.314 242.839 -36.187
201704 -25.657 244.524 -35.040
201707 -28.571 244.786 -38.978
201710 -28.114 246.663 -38.063
201801 -30.400 247.867 -40.958
201804 -29.800 250.546 -39.720
201807 -26.086 252.006 -34.569
201810 -0.243 252.885 -0.321
201903 1.077 254.202 1.415
201906 1.029 256.143 1.342
201909 1.329 256.759 1.729
201912 1.422 256.974 1.848
202003 3.033 258.115 3.924
202006 2.871 257.797 3.719
202009 2.823 260.280 3.622
202012 2.118 260.474 2.715
202103 2.520 264.877 3.177
202106 3.299 271.696 4.055
202109 2.447 274.310 2.979
202112 2.599 278.802 3.113
202203 2.479 287.504 2.879
202206 2.675 296.311 3.015
202209 2.622 296.808 2.950
202212 2.082 296.797 2.343
202303 2.012 301.836 2.226
202306 1.854 305.109 2.029
202309 1.500 307.789 1.628
202312 1.489 306.746 1.621
202403 1.471 312.332 1.573
202406 1.345 314.175 1.430
202409 1.314 315.301 1.392
202412 1.362 315.605 1.441
202503 1.310 319.799 1.368
202506 1.251 322.561 1.295
202509 1.198 324.800 1.232
202512 0.947 324.054 0.976
202603 0.907 330.213 0.917
202606 0.963 333.952 0.963

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $-6.05 mean?
Cresco Labs (CRLBF) has a Cyclically Adjusted Book per Share of $-6.05 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cresco Labs and its competitors.
Is Cresco Labs' Cyclically Adjusted Book per Share too high?
Cresco Labs' current Cyclically Adjusted Book per Share is $-6.05. Overall, Cresco Labs has a GF Score™ of 29/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Cyclically Adjusted Book per Share compare to ZTS?
Cresco Labs' Cyclically Adjusted Book per Share of $-6.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cresco Labs and its competitors. Cresco Labs's current Cyclically Adjusted Book per Share is $-6.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (CRLBF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.87, compared to a current price of $0.76 — trading 12.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is $-6.05. Cresco Labs' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cresco Labs (CRLBF), the current Cyclically Adjusted Book per Share is $-6.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cresco Labs (CRLBF) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of $0.76 is trading 12.6% below its estimated GF Value™ of $0.87. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for CRLBF:

  • Cyclically Adjusted Book per Share: $-6.05
  • GF Value™: $0.87 vs. price of $0.76 (12.6% below fair value)
  • GF Score™: 29/100 with 6 warning signs

No single metric tells the full story. See the CRLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cresco Labs Business Description

Other Exchanges 6CQ:GermanyCL:Canada
Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
29GF Score

Get the complete analysis for CRLBF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.76
Price
$0.87
GF Value